Abstract
Abstract
Background
TBL1XR1 encodes a F-box-like/WD40 repeat-containing protein that plays a role in transcription mediated by nuclear receptors and is a known genetic cause of neurodevelopmental disease of childhood (OMIM# 608628). Yet the developmental trajectory and progression of neurologic symptoms over time remains poorly understood.
Methods
We developed and distributed a survey to two closed Facebook groups devoted to families of patients with TBL1XR1-related disorder. The survey consisted of 14 subsections focused upon the developmental trajectories of cognitive, behavioral, motor, and other neurological abnormalities. Data were collected and managed using REDCap electronic data capture tools.
Results
Caregivers of 41 patients with a TBL1XR1-related disorder completed the cross-sectional survey. All reported variants affecting a single amino acid, including missense mutations and in-frame deletions, were found in the WD40 repeat regions of Tbl1xr1. These are domains considered important for protein–protein interactions that may plausibly underlie disease pathology. The majority of patients were diagnosed with a neurologic condition before they received their genetic diagnosis. Language appeared most significantly affected with only a minority of the cohort achieving more advanced milestones in this domain.
Conclusion
TBL1XR1-related disorder encompasses a spectrum of clinical presentations, marked by early developmental delay ranging in severity, with a subset of patients experiencing developmental regression in later childhood.
Funder
Rare Diseases Clinical Research Network
Massachusetts General Hospital
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Rosello R, Martinez-Raga J, Tomas JM, Mira A, Cortese S. Cognitive and behavioral profiles in children with autism spectrum disorder with and without attention-deficit/hyperactivity disorder. Child Adolesc Ment Health. 2022. https://doi.org/10.1111/camh.12562.
2. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, Tseng LA, Houben R, Stöckler-Ipsiroglu S, et al. Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app. Orphanet J Rare Dis. 2021;16:170.
3. EuroEPINOMICS RES Consortium, Heyne HO, Singh T, Stamberger H, AbouJamra R, Caglayan H, et al. De novo variants in neurodevelopmental disorders with epilepsy. Nat Genet. 2018;50(7):1048–53.
4. Ellis K, Moss J, Stefanidou C, Oliver C, Apperly I. The development of early social cognitive skills in neurogenetic syndromes associated with autism: Cornelia de Lange, fragile X and Rubinstein–Taybi syndromes. Orphanet J Rare Dis. 2021;16:488.
5. Riggs ER, Bingaman TI, Barry CA, Behlmann A, Bluske K, Bostwick B, et al. Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panels. Genet Med. 2022;S1098360022007560.